Synopsis
Recognise the reciprocal breathlessness-panic cycle without overlooking respiratory emergencies, teach immediate recovery skills, address illness understanding and avoidance, and use psychological or pharmacological treatment according to onset, goals and respiratory safety.
- Validate the sensation without assuming its cause: panic can intensify breathlessness, and respiratory pathology can trigger genuine panic simultaneously.
- First-line crisis care is presence, upright supported posture, cool facial airflow, one calm speaker and a slow exhalation-focused breathing pattern.
- Use short grounding prompts: name what is happening, orient to the room, relax shoulders and match activity to a safe recovery position.
- After recovery, map triggers, thoughts, bodily sensations, behaviour, duration, rescue use and how carers respond; identify what differs from medical emergencies.
- Breathing retraining, cognitive behavioural strategies, pulmonary rehabilitation, pacing and graded re-engagement are first-line continuing treatments.
- A low-dose opioid may treat refractory breathlessness, not panic itself; an anxiolytic may address severe panic, not hypoxaemia or obstruction.
- Lorazepam can be used as carefully prescribed rescue for severe recurrent anxiety when non-drug measures fail, but respiratory and dependence risks require review.
- An SSRI can treat persistent panic or anxiety over weeks; explain initial activation, interactions and delayed benefit and provide follow-up.
- The gold-standard plan teaches the patient and carer how to distinguish expected episodes from red flags and specifies techniques, medicines, call route and escalation ceiling.
Key red flags
A first or changed panic-like episode with hypoxaemia, focal signs, pleuritic pain, haemoptysis or syncope requires urgent cardiopulmonary evaluation.
Falling respiratory effort, drowsiness or carbon-dioxide retention is respiratory failure, not resolution of anxiety.
Suicidal intent, inability to remain safe, severe depression or requests to hasten death requires direct same-day risk assessment.
Benzodiazepine plus opioid, alcohol, gabapentinoid or hypercapnic lung disease materially increases sedation and respiratory risk.
Increasing unsupervised rescue use, lost tablets or demands for early supply may indicate uncontrolled symptoms, dependence, misuse or unsafe caregiver administration.
A relative controlling medication or preventing private discussion raises coercion and safeguarding concerns.
Slurred speech, unsteady gait, prolonged sleep and slowed breathing after rescue use indicates medicine harm rather than successful calming.
Investigation priorities
Check airway, respiratory rate and effort, saturation, pulse, pressure, temperature, consciousness, chest and relevant embolic or cardiac features.
Management branches
A familiar breathlessness-panic episode occurs without new emergency features.
- Stay with the patient, use one calm speaker, supported posture and facial airflow and guide a gentle prolonged exhalation without demanding deep breaths.
- Name and validate the fear, use grounding and administer only a pre-agreed patient-specific rescue when the non-drug sequence is insufficient.
- After recovery, record trigger, duration and rescue effect and practise the plan again with caregiver adjustments rather than treating the event as failure.